T/GDACM 0107-2022 Active Group standards

T/GDACM 0107-2022 Clinical Diagnosis and Treatment Guidelines for Early Breast Cancer (Mammary Carcinoma) Combining Traditional Chinese Medicine and Western Medicine

T/GDACM 0107-2022

Publish Date: 2022-04-21 Implement Date: 2022-04-21 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/GDACM 0107-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Terminology (principles and coordination and cooperation)

Publish Date: 2022-04-21

Implement Date: 2022-04-21

Scope

Main technical content: Breast cancer is one of the most common malignancies in women and currently one of the cancers with the highest incidence worldwide. According to data from the National Cancer Center in 2022, the global standardized incidence rate of breast cancer in Chinese women is 29.05/105, and the standardized mortality rate is 6.39/105. Although these rates are relatively low globally, they are on the rise. Due to the large population base, the number of breast cancer cases and deaths in China ranks first in the world. Compared with advanced cancer, early-stage cancer offers a chance of cure. Therefore, standardized treatment of breast cancer in the early stages is particularly important. Traditional Chinese medicine (TCM) has a long history in the prevention and treatment of breast diseases. As early as the "Huangdi Neijing", there are records about the meridians and physiology of the breast, such as "the Foot Yangming Stomach Meridian runs through the breast". The "Zhongzang Jing" in the Han Dynasty mentioned the disease of "mammalian affection", and the "Elbow-Behind Emergency Prescriptions" and "Liu Juanzi's Ghost Legacy Prescriptions" in the Jin Dynasty recorded diseases such as "mammalian abscess" and "mammalian eruption". The understanding of breast cancer appeared in the "Women's Comprehensive Prescriptions" in the Song Dynasty, which called it "mammalian rock". TCM attaches great importance to the prevention and treatment of breast diseases. For example, the "Gynecological Jade Measure" proposed that "among all diseases affecting women, none are more important than breast diseases". Through the unremitting efforts of generations of doctors, breast diseases have become a distinctive, advantageous, and effective disease category in the field of traditional Chinese medicine. In recent years, breast cancer, as one of the key diseases treated by traditional Chinese medicine, has made great progress in many aspects such as the study of syndrome patte